18 May 2012 - Developer of small molecule drugs to combat infectious diseases Achillion Pharmaceuticals Inc (Nasdaq:ACHN), announced on Friday the promotion of Gautam Shah PhD to executive vice president.

The company said that Dr Shah is also its chief compliance officer, a position he will maintain on his promotion He has previously served as the company's senior vice president.